Health-care companies fell as traders rotated back into cyclical sectors in light of promising jobs data and dovish comments from Federal Reserve Chairman Jerome Powell.

Annovis Bio's shares rallied after its buntanetap product candidate showed promise in a late-stage clinical trial on patients with early Parkinson's disease, improving motor and non-motor activities and cognitive functions.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

07-02-24 1648ET